The weekly litigation news digest is live. Subscribe now

IP Verse

Novel Antitumoral Use Of Cabazitaxel - EP2493466

The patent EP2493466 was granted to Aventis Pharma on Mar 10, 2021. The application was originally filed on Oct 27, 2010 under application number EP10782039A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP2493466

AVENTIS PHARMA
Application Number
EP10782039A
Filing Date
Oct 27, 2010
Status
Opposition Rejected
Sep 19, 2025
Publication Date
Mar 10, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (15)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

ACCORD HEALTHCARE SLUAug 30, 2024AERAINTERVENTION ADMISSIBLE
ACCORD HEALTHCARE SLUAug 30, 2024BARDEHLE PAGENBERG SLINTERVENTION ADMISSIBLE
MAIWALDDec 10, 2021MAIWALDADMISSIBLE
STADA ARZNEIMITTELDec 9, 2021HAMM & WITTKOPPADMISSIBLE
VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBBDec 3, 2021VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBBADMISSIBLE
GENERICS UKJun 8, 2021ELKINGTON AND FIFEADMISSIBLE
DR REDDYS LABORATORIES BETAPHARM ARZNEIMITTELMar 31, 2021MAIWALDADMISSIBLE
FRESENIUS KABI DEUTSCHLANDMar 23, 2021FRESENIUS KABI DEUTSCHLANDADMISSIBLE
MEDAC GESELLSCHAFT FUR KLINISCHE SPEZIALPRAPARATEMar 22, 2021UEXKULL & STOLBERGWITHDRAWN
ZENTIVA KSMar 12, 2021GREINERADMISSIBLE
EVER VALINJECTMar 12, 2021SONN PATENTANWALTEWITHDRAWN
ACCORD HEALTHCAREMar 10, 2021AERAADMISSIBLE
ACCORD HEALTHCAREMar 10, 2021BARDEHLE PAGENBERG SLADMISSIBLE
GLENMARK PHARMACEUTICALS EUROPEMar 10, 2021BRAND MURRAY FULLERADMISSIBLE
TEVA PHARMACEUTICALSMar 10, 2021KRAUS & LEDERER PARTGMBBWITHDRAWN

Patent Citations (10) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP0817779
DESCRIPTIONUS5847170
DESCRIPTIONWO2005002846
DESCRIPTIONWO9630355
INTERNATIONAL-SEARCH-REPORTEP2177630
INTERNATIONAL-SEARCH-REPORTUS2005065138
OPPOSITIONUS2005065138
OPPOSITIONWO2005028462
OPPOSITIONWO9630355
OTHEREP2493466

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents